MSTN and chronic kidney disease: Recently, Zhang et al. reported that myostatin expression in muscle was increased in patients with CKD8 as well as five-sixth nephrectomized mice (CKD mice), and that the administration of anti-myostatin anti-peptide to these mice suppressed the reducing of muscle mass9, 10.